Skip Nav Destination
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma
Issue Archive
Table of Contents
BLOOD COMMENTARIES
PLENARY PAPER
PLATELETS AND THROMBOPOIESIS
TNF-α–driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging
Pavel Davizon-Castillo,Brandon McMahon,Sonia Aguila,David Bark,Katrina Ashworth,Ayed Allawzi,Robert A. Campbell,Emilie Montenont,Travis Nemkov,Angelo D’Alessandro,Nathan Clendenen,Lauren Shih,Natalie A. Sanders,Kelly Higa,Allaura Cox,Zavelia Padilla-Romo,Giovanni Hernandez,Eric Wartchow,George D. Trahan,Eva Nozik-Grayck,Kenneth Jones,Eric M. Pietras,James DeGregori,Matthew T. Rondina,Jorge Di Paola
BLOOD SPOTLIGHT
REVIEW ARTICLE
LYMPHOID NEOPLASIA
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma
Clinical Trials & Observations
Brief Report
Ciara L. Freeman,Robert Kridel,Alden A. Moccia,Kerry J. Savage,Diego R. Villa,David W. Scott,Alina S. Gerrie,David Ferguson,Fergus Cafferty,Graham W. Slack,Pedro Farinha,Brian Skinnider,Joseph M. Connors,Laurie H. Sehn
PLATELETS AND THROMBOPOIESIS
TRANSPLANTATION
LETTER TO BLOOD
BLOOD WORK
-
Cover Image
Cover Image
Fluorescence microscopy image of hyaluronan (green) and inter-α inhibitor (red) in a murine model of colitis. The image shows leukocyte-adhesive hyaluronan matrices which surround intestinal microvessels and accumulate in the vessel lumen during inflammation. See the article by Petrey et al on page 765.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals